Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

General

Canada-US Tariff War Puts Critical-Mineral ETFs Back in Focus
Canada-US Tariff War Puts Critical-Mineral ETFs Back in Focus
Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens
Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens
Summit Therapeutics Says Ivonescimab Combination Extends Progression-Free Survival in Lung Cancer Patients
Summit Therapeutics Says Ivonescimab Combination Extends Progression-Free Survival in Lung Cancer Patients
Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens
Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens
Summit Therapeutics Says Ivonescimab Combination Extends Progression-Free Survival in Lung Cancer Patients
Summit Therapeutics Says Ivonescimab Combination Extends Progression-Free Survival in Lung Cancer Patients
QUICK SPARK: Nvidia-Backed Biotech Says AI Could Make Biology Programmable
QUICK SPARK: Nvidia-Backed Biotech Says AI Could Make Biology Programmable
EXCLUSIVE: Nvidia's Biggest Contribution to AI Drug Discovery Isn't Money, Generate CTO Says
EXCLUSIVE: Nvidia's Biggest Contribution to AI Drug Discovery Isn't Money, Generate CTO Says

General Recent News

What'sGoing On With AbCellera Biologics Stock On Tuesday?
What'sGoing On With AbCellera Biologics Stock On Tuesday?
AbCellera Biologics stock gains as investors react to Jazz Pharmaceuticals’ FDA approval and the companies’ antibody partnership.
Greenland Mines Outlines $2B Valuation for Sarfartoq Project
Greenland Mines Outlines $2B Valuation for Sarfartoq Project
Greenland Mines released an Initial Assessment for its Sarfartoq project, projecting a pre-tax net present value up to $2.05 billion.
This Treasury Strategy Could Backfire on Fed — Top Economists Warn Scott Bessent Is Mucking With a Critical Market Signal
This Treasury Strategy Could Backfire on Fed — Top Economists Warn Scott Bessent Is Mucking With a Critical Market Signal
Jeremy Siegel warns of the 'Bessent Twist' in Treasury buybacks, while Ed Yardeni says the intervention will 'muck up things' for the Fed.
Johnson & Johnson Secures FDA Approval For First Rare Anemia Treatment
Johnson & Johnson Secures FDA Approval For First Rare Anemia Treatment
Johnson & Johnson secured FDA approval for IMAAVY, the first targeted therapy to treat warm autoimmune hemolytic anemia in adults and youth.
SpaceX's AI Push Comes Into Focus as JPMorgan Sees Nearly 80% Upside
SpaceX's AI Push Comes Into Focus as JPMorgan Sees Nearly 80% Upside
Grok's functions—including its lack of safeguards—have received significant industry backlash. Still, JPMorgan remains bullish.
China Is Winning Big From Trump’s 'Self-Inflicted Quagmire' in Iran, Paul Krugman Warns: ‘...Smell the Scent of Desperation’
China Is Winning Big From Trump’s 'Self-Inflicted Quagmire' in Iran, Paul Krugman Warns: ‘...Smell the Scent of Desperation’
Economist Paul Krugman explains why China is the true winner of Trump's "self-inflicted quagmire" in Iran and why U.S. sanctions will fail.
Elon Musk's Tesla Hikes Cybertruck Prices by More Than 7% Despite Sluggish Sales
Elon Musk's Tesla Hikes Cybertruck Prices by More Than 7% Despite Sluggish Sales
Tesla raised Cybertruck prices in the U.S. for some trim levels, with the entry-level trim now priced $15,000 higher than at launch.
Canada Threatens Trump’s Industrial Achilles' Heel
Canada Threatens Trump’s Industrial Achilles' Heel
U.S.-Canada trade war escalates as Ontario threatens to cut critical mineral and power exports over 50% tariffs.
Adam Schiff Slams Trump’s Freedom 250 Race as ‘Spectacle’ Amid $4 Gas, Graham Rahal Fires Back
Adam Schiff Slams Trump’s Freedom 250 Race as ‘Spectacle’ Amid $4 Gas, Graham Rahal Fires Back
Schiff accuses Trump of using IndyCar race as a political distraction from gas prices. Rahal defends race as privately funded and unifying.
Elon Musk Reveals Why SpaceX Launched Tesla’s Roadster Into Orbit: ‘We Didn’t Want to Risk Anything Valuable’
Elon Musk Reveals Why SpaceX Launched Tesla’s Roadster Into Orbit: ‘We Didn’t Want to Risk Anything Valuable’
SpaceX launched Elon Musk's Tesla Roadster to orbit Earth and Mars in 2018 to avoid risking anything valuable, the billionaire said.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved